Events & Training for May 2020

Highly Potent Active Pharmaceutical Ingredients 2020

11 May 2020 - 12 May 2020

Announcement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.superbugssuperdrugs.com/ The 4th year of this conference series focuses on the growing HPAPI landscape driven by the demand for highly potent drugs in oncology, diabetes and autoimmune disease treatment. This event will address the biggest challenges the industry is facing with regards to determining toxicology limits, assessing hazards, implementing risk procures, translating risk assessment into facility engineering, preventing and dealing with cross-contamination and adhering to GMP regulatory guidelines.

Copthorne Tara Hotel, London, UK

http://www.highlypotentapi.com/ddtoday

SMi’s 20th Annual Pain Therapeutics Conference

11 May 2020 - 12 May 2020

Announcement: Due to ongoing concerns over COVID-19 this conference is now available with remote access only – please register your place at www.pain-therapeutics.co.uk The 20th Annual Conference will overview the current state of pain treatment starting with research essentials including choosing the right preclinical models to overviewing clinical success up to date, highlighting cutting-edge research and evaluating the potential of drug candidates in the pipelines of leading pharmaceuticals. This year we are introducing the Pain Research Essentials theme to closely observe analgesics drug development from a preclinical point of view. Within this theme talks will address the latest biomarker discoveries, bridging the translational gap, differences of pain pathology across sexes and consequently, the need for distinct gender animal models. This will be topped with a panel discussion around novel drug targets in neuropathic pain treatment. Presentations on clinical stage research will highlight current struggles of opioid-based treatments and discuss results of treatments with non-opioid targets; such as the recently researched cannabinoid receptor 2, nociception/orphanin FQ peptide (NOP) receptor, ENKephalinase and NGF receptors. Furthermore, neuro-immune interactions and their role in pain pathology will be discussed as an anticipated approach for providing more effective therapy for chronic pain. Additionally, the therapeutic efficacy of neurotoxins will be addressed exploring novel botulinum-based constructs. Join SMi’s leading Pain Therapeutics Conference which will explore the cutting-edge research of novel therapeutics in the pipeline of leading pharmaceutical companies and discuss solutions for the challenges of understanding pain as a heterogenous disease and the diverse treatment approaches it requires. Event Hashtag: #SMiPain

REMOTE ACCESS ONLY

http://www.pain-therapeutics.co.uk/ddt

Lab of the Future USA

19 May 2020 - 20 May 2020

Lab of the Future USA - to be held on 19th & 20th May Boston MA - follows the ground-breaking congress held in Europe in 2019. A multi tack Conference and exhibition with Live Lab breakouts, the Congress brings together the collaborative research strategies with digitalisation programmes and automation to create the perfect platform and environment for scientists to deliver the next generation of treatments to patients.

Hilton Back Bay, Boston, MA, USA

https://www.lab-of-the-future.com/USA/